首页
OALib 期刊
快速投稿通道
我的图书馆
常见问题
关于我们
关注我们+
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
LinkedIn (OALib Group)
LinkedIn (OALib Company Page)
Facebook
Twitter
全部
标题
作者
关键词
摘要
OALib Journal期刊
ISSN: 2333-9721
费用:99美元
投递稿件
为什么选择我们?
>>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎
-
ISSN Print:
ISSN Online:
主页:
https://pubs.acs.org/journal/amclct
分享:
Go
Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3-d]pyrimidine-Based Antiproliferative Multikinase Inhibitors
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease
Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists
Deciphering the Nonsense Readthrough Mechanism of Action of Ataluren: An in Silico Compared Study
Scaffold Morphing Approach To Expand the Toolbox of Broad-Spectrum Antivirals Blocking Dengue/Zika Replication
Focusing on Relevance: CETSA-Guided Medicinal Chemistry and Lead Generation
Inhibition Mechanism of Urease by Au(III) Compounds Unveiled by X-ray Diffraction Analysis
Mass Spectrometry-based Label-free Quantitative Proteomics To Study the Effect of 3PO Drug at Cellular Level
Covalent Inhibitors of Plasmodium falciparum Glyceraldehyde 3-Phosphate Dehydrogenase with Antimalarial Activity in Vitro
Engineering Chemistry Innovation
CBD: A New Hope?
Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition
Hybridization of Fluoro-amodiaquine (FAQ) with Pyrimidines: Synthesis and Antimalarial Efficacy of FAQ–Pyrimidines
Identification of a Strigoterpenoid with Dual Nrf2 and Nf-κB Modulatory Activity
2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides
Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity
Simplifying the Chemical Structure of Cationic Lipids for siRNA-Lipid Nanoparticles
Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs
Stereoselective Synthesis of C-2 Alkylated Trihydroxypiperidines: Novel Pharmacological Chaperones for Gaucher Disease
Development of α-GalCer Analogues with an α-Fluorocarbonyl Moiety as Th2-Selective Ligands of CD1d
Synthesis, Biological Evaluation and Structure–Activity Relationships of Diflapolin Analogues as Dual sEH/FLAP Inhibitors
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor
Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists
Diacetal Ditellurides as Highly Active and Selective Antiparasitic Agents toward Leishmania amazonensis
Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927
Reducing Limitation in Probe Design: The Development of a Diazirine-Compatible Suzuki–Miyaura Cross Coupling Reaction
In Vivo Anticancer Activity of a Rhenium(I) Tricarbonyl Complex
Second-Generation Tryptamine Derivatives Potently Sensitize Colistin Resistant Bacteria to Colistin
Rational Design of Cell-Active Inhibitors of PARP10
Synthesis of a 6-Aza-Isoindolinone-Based Inhibitor of Phosphoinositide 3-Kinase γ via Ruthenium-Catalyzed [2 + 2 + 2] Cyclotrimerization
Aminopyrazole Carboxamide Bruton’s Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning
Optimizing the Pharmacological Profile of New Bifunctional Antihyperlipidemic/Antioxidant Morpholine Derivatives
Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders
Discovery of VU2957 (Valiglurax): An mGlu4 Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson’s Disease
Synthesis, Profiling, and in Vivo Evaluation of Cyclopeptides Containing N-Methyl Amino Acids as Antiplasmodial Agents
Modulation of AMPA Receptor Gating by the Anticonvulsant Drug, Perampanel
Di-aryl Sulfonamide Motif Adds π-Stacking Bulk in Negative Allosteric Modulators of the NMDA Receptor
Unnatural Tripeptides as Potent Positive Allosteric Modulators of T1R2/T1R3
Discovery of CDK5 Inhibitors through Structure-Guided Approach
Atorvastatin (Lipitor) by MCR
Structure–Activity Relationship Studies of 3- or 4-Pyridine Derivatives of DS-6930
Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1)
Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties
18F-Labeled PET Probe Targeting Enhancer of Zeste Homologue 2 (EZH2) for Cancer Imaging
Enhancing Drug Residence Time by Shielding of Intra-Protein Hydrogen Bonds: A Case Study on CCR2 Antagonists
Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues
Discovery of Imidazo[1,2-a]pyrazines and Pyrazolo[1,5-c]pyrimidines as TARP γ-8 Selective AMPAR Negative Modulators
Idea2Data: Toward a New Paradigm for Drug Discovery
Go